Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	181.54	75.62	-	-	-	-
Cost of Revenue	130.57	112.86	103.37	-	-	-
Gross Profit	50.97	-37.24	-103.37	-	-	-
Selling, General & Admin	42.46	43.87	39.94	35.12	15.73	4.01
Research & Development	-	-	-	77.26	57.16	24.01
Operating Expenses	42.46	43.87	39.94	112.38	72.88	28.01
Operating Income	8.51	-81.11	-143.31	-112.38	-72.88	-28.01
Interest & Investment Income	11.85	10.57	9.33	3.76	0.05	0.01
Currency Exchange Gain (Loss)	1.54	0.42	-0.93	0.01	-0.16	-0.2
Other Non Operating Income (Expenses)	-	-	-	-	-0.96	-7.68
EBT Excluding Unusual Items	21.9	-70.13	-134.91	-108.61	-73.96	-35.88
Gain (Loss) on Sale of Investments	-	-	-0.13	-	-	-
Gain (Loss) on Sale of Assets	0.06	-	0.02	0.11	-	-
Pretax Income	21.95	-70.13	-135.01	-108.5	-73.96	-35.88
Income Tax Expense	1.01	2.57	0.34	-	-	-
Net Income	20.95	-72.7	-135.35	-108.5	-73.96	-35.88
Net Income to Common	20.95	-72.7	-135.35	-108.5	-73.96	-35.88
Shares Outstanding (Basic)	82	74	51	47	25	2
Shares Outstanding (Diluted)	83	74	51	47	25	2
Shares Change (YoY)	22.34%	43.80%	8.83%	88.91%	1548.09%	7.11%
EPS (Basic)	0.25	-0.98	-2.63	-2.30	-2.96	-23.65
EPS (Diluted)	0.25	-0.98	-2.63	-2.30	-2.96	-23.65
Free Cash Flow	145.02	38.01	-62.84	-105.38	-69.1	-26.44
Free Cash Flow Per Share	1.75	0.51	-1.22	-2.23	-2.76	-17.43
Gross Margin	28.08%	-49.25%	-	-	-	-
Operating Margin	4.69%	-107.26%	-	-	-	-
Profit Margin	11.54%	-96.14%	-	-	-	-
Free Cash Flow Margin	79.88%	50.26%	-	-	-	-
EBITDA	16.84	-72.99	-137.09	-108.64	-70.75	-27.47
EBITDA Margin	9.28%	-96.52%	-	-	-	-
D&A For EBITDA	8.33	8.12	6.22	3.75	2.13	0.54
EBIT	8.51	-81.11	-143.31	-112.38	-72.88	-28.01
EBIT Margin	4.69%	-107.26%	-	-	-	-

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q